Mink Therapeutics (INKT) AGM 2026 summary

Opening remarks and agenda

• Meeting called to order by the CEO, with board members and key executives present.

• Formal portion of the meeting initiated, confirming notice and record date for stockholders.

Corporate governance

• Inspector of Elections appointed and sworn in to oversee voting and ensure impartiality.

• Quorum established with proxies representing 66% of outstanding shares.

• Voting procedures explained, with no additional shareholder proposals received.

Overview of voting outcomes

• Election of three Class II directors for three-year terms approved.

• Ratification of KPMG LLP as independent auditor for fiscal year 2026 approved.

• Preliminary or final voting results to be reported on Form 8-K within four business days.